TORONTO DOMINION BANK

Bank

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 947263 TORONTO, ONTARIO, A6

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,813,080

+$2,390,650 QoQ

Shares Held

144,928

-3.6% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#88

of 497 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TORONTO DOMINION BANK holds $769,395,513 across 60 Biotechnology names. ARWR ranks #12 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTCT	Ptc Therapeutics, Inc.	2,165,846	$176,668,057
2	CELC	Celcuity Inc.	1,258,758	$131,691,261
3	STOK	Stoke Therapeutics, Inc.	3,173,258	$103,829,001
4	MDGL	Madrigal Pharmaceuticals, Inc.	181,432	$97,419,912
5	VRTX	Vertex Pharmaceuticals Inc / Ma	85,391	$42,416,270
6	TARS	Tarsus Pharmaceuticals, Inc.	510,253	$32,115,323
7	REGN	Regeneron Pharmaceuticals, Inc.	48,783	$30,418,151
8	NGNE	Neurogene Inc.	681,337	$21,428,048

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,813,080	144,928	-3.6%	Shares	Defined	2026-08-14
2026-03-31	$9,422,430	150,278	+5009166.7%	Shares	Defined	2026-05-15
2024-06-30	$77	3	0.0%	Shares	Defined	2024-08-14
2024-03-31	$85	3	0.0%	Shares	Defined	2024-05-14
2023-12-31	$91	3	0.0%	Shares	Defined	2024-02-13
2023-09-30	$80	3	0.0%	Shares	Defined	2024-02-14
2023-06-30	$106	3	-62.5%	Shares	Defined	2024-02-14
2020-12-31	$613	8	0.0%	Shares	Defined	2021-02-08
2020-09-30	$344	8	0.0%	Shares	Defined	2020-10-30
2020-06-30	$345	8	—	Shares	Defined	2020-08-28
No filing history on record for this holder in this stock.